These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 22226485)

  • 21. Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System.
    Li C; Barker L; Ford ES; Zhang X; Strine TW; Mokdad AH
    Diabet Med; 2008 Jul; 25(7):878-81. PubMed ID: 18644077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system.
    Li C; Ford ES; Strine TW; Mokdad AH
    Diabetes Care; 2008 Jan; 31(1):105-7. PubMed ID: 17934145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare utilization and diabetes management programs: Indiana 2006-2010.
    Mayo-Gamble TL; Lin HC
    Am J Manag Care; 2014 Oct; 20(10):e461-8. PubMed ID: 25414984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among U.S. adults with diagnosed diabetes: findings from the 2009 Behavioral Risk Factor Surveillance System.
    Li C; Zhao G; Okoro CA; Wen XJ; Ford ES; Balluz LS
    Diabetes Care; 2013 Jun; 36(6):1569-76. PubMed ID: 23300288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes.
    Yeaw J; Lee WC; Aagren M; Christensen T
    J Manag Care Pharm; 2012; 18(1):21-32. PubMed ID: 22235952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in a real-world population with type 2 diabetes: Results from a European, multicentre, retrospective chart review study.
    Price H; Blüher M; Prager R; Phan TM; Thorsted BL; Schultes B;
    Diabetes Obes Metab; 2018 Apr; 20(4):954-962. PubMed ID: 29205856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin.
    Evans M; Billings LK; Håkan-Bloch J; Slothuus U; Abrahamsen TJ; Andersen A; Jansen JP
    J Med Econ; 2018 Apr; 21(4):340-347. PubMed ID: 29164973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis.
    Cai X; Gao X; Yang W; Ji L
    Expert Opin Pharmacother; 2017 Dec; 18(17):1789-1798. PubMed ID: 29090600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).
    Buse JB; Vilsbøll T; Thurman J; Blevins TC; Langbakke IH; Bøttcher SG; Rodbard HW;
    Diabetes Care; 2014 Nov; 37(11):2926-33. PubMed ID: 25114296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA.
    Hunt B; Mocarski M; Valentine WJ; Langer J
    J Med Econ; 2017 Jul; 20(7):663-670. PubMed ID: 28294641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes.
    Dall TM; Yang W; Halder P; Pang B; Massoudi M; Wintfeld N; Semilla AP; Franz J; Hogan PF
    Diabetes Care; 2014 Dec; 37(12):3172-9. PubMed ID: 25414388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How many people inject insulin? UK estimates from 1991 to 2010.
    Holden SE; Gale EA; Jenkins-Jones S; Currie CJ
    Diabetes Obes Metab; 2014 Jun; 16(6):553-9. PubMed ID: 24410846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.
    Rodriguez LA; Finertie H; Neugebauer RS; Gosiker B; Thomas TW; Karter AJ; Gilliam LK; Oshiro C; An J; Simonson G; Cassidy-Bushrow AE; Dombrowski S; Nolan M; O'Connor PJ; Schmittdiel JA
    Lancet Reg Health Am; 2024 Jun; 34():100759. PubMed ID: 38745886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs and Health Care Utilization Analysis of Medical Group Visits for Adults With Type 2 Diabetes in Community Health Centers.
    Wan W; Staab EM; Li J; GoodSmith M; Campbell A; Schaefer CT; Quinn MT; Huang ES; Baig AA
    Med Care; 2023 Dec; 61(12):866-871. PubMed ID: 37819210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in Out-of-Pocket Cost of Glucagon, 2010-2020.
    Zupa M; Feldman R; Luo J
    JAMA Netw Open; 2022 Aug; 5(8):e2229428. PubMed ID: 36040744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of geographic disparities of pre-diabetes and diabetes in Florida.
    Lord J; Roberson S; Odoi A
    BMC Public Health; 2020 Aug; 20(1):1226. PubMed ID: 32787830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register.
    Kong APS; Lew T; Lau ESH; Lim LL; Kesavadev J; Jia W; Sheu WH; Sobrepena L; Tan ATB; Nguyen TK; Yoon KH; Wang K; Kodiappan K; Treuer T; Chan JCN;
    Diabetes Obes Metab; 2020 Apr; 22(4):669-679. PubMed ID: 31903728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea.
    Choi SH; Oh TJ; Jang HC
    Diabetes Metab J; 2017 Jun; 41(3):170-178. PubMed ID: 28537056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes distress from the patient's perspective: Qualitative themes and treatment regimen differences among adults with type 2 diabetes.
    Tanenbaum ML; Kane NS; Kenowitz J; Gonzalez JS
    J Diabetes Complications; 2016 Aug; 30(6):1060-8. PubMed ID: 27217023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.